Du XJ - Search Results

1

Ultrafast charge-conversional nanocarrier for tumor-acidity-activated targeted drug elivery.

Liu J , Iqbal S , Du XJ , Yuan Y , Yang X , Li HJ , Wang J . Liu J , et al. Among authors: du xj. Biomater Sci. 2018 Jan 30;6(2):350-355. doi: 10.1039/c7bm01025g. Biomater Sci. 2018. PMID: 29265134

2

Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.

Du JZ, Du XJ, Mao CQ, Wang J. Du JZ, et al. Among authors: du xj. J Am Chem Soc. 2011 Nov 9;133(44):17560-3. doi: 10.1021/ja207150n. Epub 2011 Oct 17. J Am Chem Soc. 2011. PMID: 21985458

3

Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor.

Yuan YY, Mao CQ, Du XJ, Du JZ, Wang F, Wang J. Yuan YY, et al. Among authors: du xj, du jz. Adv Mater. 2012 Oct 23;24(40):5476-80. doi: 10.1002/adma.201202296. Epub 2012 Aug 9. Adv Mater. 2012. PMID: 22886872

4

Differential anticancer drug delivery with a nanogel sensitive to bacteria-accumulated tumor artificial environment.

Xiong MH, Bao Y, Du XJ, Tan ZB, Jiang Q, Wang HX, Zhu YH, Wang J. Xiong MH, et al. Among authors: du xj. ACS Nano. 2013 Dec 23;7(12):10636-45. doi: 10.1021/nn403146t. Epub 2013 Nov 18. ACS Nano. 2013. PMID: 24200225

5

Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy.

Yang XZ, Du XJ, Liu Y, Zhu YH, Liu YZ, Li YP, Wang J. Yang XZ, et al. Among authors: du xj. Adv Mater. 2014 Feb 12;26(6):931-6. doi: 10.1002/adma.201303360. Epub 2013 Dec 16. Adv Mater. 2014. PMID: 24338636

6

Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery.

Mao CQ, Xiong MH, Liu Y, Shen S, Du XJ, Yang XZ, Dou S, Zhang PZ, Wang J. Mao CQ, et al. Among authors: du xj. Mol Ther. 2014 May;22(5):964-73. doi: 10.1038/mt.2014.18. Epub 2014 Feb 5. Mol Ther. 2014. PMID: 24496383 Free PMC article.

7

Cationic lipid-assisted polymeric nanoparticle mediated GATA2 siRNA delivery for synthetic lethal therapy of KRAS mutant non-small-cell lung carcinoma.

Shen S, Mao CQ, Yang XZ, Du XJ, Liu Y, Zhu YH, Wang J. Shen S, et al. Among authors: du xj. Mol Pharm. 2014 Aug 4;11(8):2612-22. doi: 10.1021/mp400714z. Epub 2014 Feb 20. Mol Pharm. 2014. PMID: 24521262

8

Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells.

Sun R, Liu Y, Li SY, Shen S, Du XJ, Xu CF, Cao ZT, Bao Y, Zhu YH, Li YP, Yang XZ, Wang J. Sun R, et al. Among authors: du xj. Biomaterials. 2015 Jan;37:405-14. doi: 10.1016/j.biomaterials.2014.10.018. Epub 2014 Oct 23. Biomaterials. 2015. PMID: 25453968

9

Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy.

Shen S, Du XJ, Liu J, Sun R, Zhu YH, Wang J. Shen S, et al. Among authors: du xj. J Control Release. 2015 Jun 28;208:14-24. doi: 10.1016/j.jconrel.2014.12.043. Epub 2015 Jan 7. J Control Release. 2015. PMID: 25575864

10

A block copolymer of zwitterionic polyphosphoester and polylactic acid for drug delivery.

Sun R, Du XJ, Sun CY, Shen S, Liu Y, Yang XZ, Bao Y, Zhu YH, Wang J. Sun R, et al. Among authors: du xj. Biomater Sci. 2015 Jul;3(7):1105-13. doi: 10.1039/c4bm00430b. Epub 2015 Mar 4. Biomater Sci. 2015. PMID: 26221944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters